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Abstract
Background: Dying at home and dying at the preferred place of death are advocated to be desirable outcomes of palliative
care. More insight is needed in their usefulness as quality indicators. Our objective is to describe whether ‘‘the percentage of
patients dying at home’’ and ‘‘the percentage of patients who died in their place of preference’’ are feasible and informative
quality indicators.
Methods and Findings: A mortality follow-back study was conducted, based on data recorded by representative GP
networks regarding home-dwelling patients who died non-suddenly in Belgium (n = 1036), the Netherlands (n = 512), Italy
(n = 1639) or Spain (n = 565). ‘‘The percentage of patients dying at home’’ ranged between 35.3% (Belgium) and 50.6% (the
Netherlands) in the four countries, while ‘‘the percentage of patients dying at their preferred place of death’’ ranged
between 67.8% (Italy) and 86.0% (Spain). Both indicators were strongly associated with palliative care provision by the GP
(odds ratios of 1.55–13.23 and 2.30–6.63, respectively). The quality indicator concerning the preferred place of death offers a
broader view than the indicator concerning home deaths, as it takes into account all preferences met in all locations.
However, GPs did not know the preferences for place of death in 39.6% (the Netherlands) to 70.3% (Italy), whereas the
actual place of death was known in almost all cases.
Conclusion: GPs know their patients’ actual place of death, making the percentage of home deaths a feasible indicator for
collection by GPs. However, patients’ preferred place of death was often unknown to the GP. We therefore recommend
using information from relatives as long as information from GPs on the preferred place of death is lacking. Timely
communication about the place where patients want to be cared for at the end of life remains a challenge for GPs.
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Introduction
The majority of people, both the general public and terminally
ill patients, prefer to die at home [1–4]. Therefore, the place where
people die has received a great deal of interest in the last few
decades and is now an extensively studied subject worldwide [5–
11]. The proportion of people dying at home ranges from 12% to
60% [4,6–10,12–14]. Traditionally, palliative care professionals
have tried to ensure that people are cared for at home until the
end of life [15–17], considering dying at home as more natural
[18]. Home deaths may be considered as an outcome of high
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quality palliative care. The view of the home as the optimal place
to die has been challenged, with the establishment of palliative
care in hospitals, nursing homes, hospices and other in-patient
facilities [17,19]. Interpreting the proportion of home deaths as an
indicator of high-quality palliative care implies that people who
were not able to die at home only received second-best care [20–
22]. Not being able to die at home could therefore be seen as a
failure in the care given to these patients, even if the patient was
actually admitted to e.g. a hospital or hospice for perfectly valid
reasons and in accordance with the patient’s wishes [15,20].
Looking at whether patients die at their preferred place may
therefore do more justice to the diversity of characteristics and
preferences of patients. Some authors have therefore stated that
ensuring death occurs in the preferred place is a more appropriate
reflection of the quality than the proportion of home deaths
[2,10,23–25]. Their main criticisms of home deaths as a quality
indicator are that this implies a home death is optimal for the
patients whereas it is not always realistic [5,8,10,15,17,22,26–29],
due to the high burden on informal caregivers, the inadequate
quality and quantity of resources in the home situation and the
unrelieved suffering. On top of that and partly for the same
reasons, a minority of patients do prefer other care locations in
contrast to the majority of patients who prefer to die at home
[3,26,30–33]. Therefore, whether patients die at their preferred
place has only recently started to receive attention [1,31,32,34,35].
Studies show that people die at the preferred place of death in
29% to 94% of cases [1,2,26].
The actual place where people die and whether people die at
their preferred place are often mentioned in studies aiming at
improving care at the end of life, suggesting that they could
function as indicators of the quality of palliative care [1,24,36–40].
Quality indicators are explicitly defined, measurable items
referring to the outcomes, processes or structure of care [41,42].
A recent systematic review [43] revealed over 300 quality
indicators developed for palliative care; this included indicators
focusing on the place of death and preferred place of death, but to
our knowledge their actual function as indicators of the quality of
care has never been studied in detail [15]. Considering the
growing attention paid to quality indicators in recent years
[43,44], studying the actual place of death and preferred place of
death from a quality indicator perspective could provide useful
new insights.
In this paper, we want to ascertain whether the quality
indicators ‘the percentage of patients dying at home’ and ‘the
percentage of patients who died in their place of preference’ are
feasible and informative quality indicators. This paper aims to
answer the following research questions in a population of patients
who died non-suddenly and who were living at home in the last
month of life in Belgium, the Netherlands, Italy and Spain:
N What are the scores of the two quality indicators for home-
dwelling patients with a non-sudden death in Belgium, the
Netherlands, Italy and Spain?
N Are these quality indicators feasible in terms of the number of
missing values when derived from the data of representative
general practitioner (GP) networks?
N Are quality differences between countries revealed in these
indicator scores? What kind of information do the two quality
indicators give us in terms of measured quality? Do they
overlap, or should they be used in combination?
N Are the expected differences in quality indicator scores
between countries related to differences in care characteristics
(adjusting for differences in patient characteristics)? If so, this
means that influencing these care characteristics may lead to
more patient-centred care, reflected in higher indicator scores,
meaning more people would die at home and/or at their
preferred place.
Methods
Study Design
Data came from the European Sentinel GP Networks Moni-
toring End-of-Life Care (EURO SENTI-MELC) study, a mortal-
ity follow-back study on monitoring end-of-life care in four
European countries, namely Belgium, the Netherlands, Spain and
Italy. For this study, we used data from the nationally represen-
tative GP networks collected in 2009 (all countries except Spain),
2010 (all four countries) and 2011 (Spain only). The GP sentinel
networks cover 1.8% and 0.8% of the Belgian and Dutch national
populations respectively [45–47]. The Spanish sentinel network
represents 3.5% of the patient population in the Castilla and Leo´n
region (in the northwest) and 2.2% in the Valencia region (in the
east) [47,48]. The Italian data came from a new GP network set up
for this study [49] and were collected from nine of the 146 health
districts, covering about 4% of the patient population [47].
Study Population
The recorded data were analysed of deceased adult patients
(aged 18 and above), who were part of a GP’s practice and had
died non-suddenly according to their GP. Since this study
examines the care delivered at the end of life, the data of people
who died suddenly and unexpectedly according to their GP were
excluded, leaving a population that was eligible for palliative care
[45]. Furthermore, the data of deceased people who had been
living in long-term care facilities (nursing homes, residential homes
or care homes) for more than 15 days in the last month of life were
excluded in all four countries. This choice was made since we were
primarily interested in the place of death and preferred place of
death of people mainly living at home, and also to enhance
comparability of the datasets of the four countries involved since
the Dutch SENTI-MELC data set did not include nursing-home
residents (in Dutch nursing homes, elderly-care physicians have
the medical responsibility rather than GPs [50]). Figure 1 shows a
flowchart of the selected sample.
Selected Quality Indicators
For the selection of the quality indicators, we used a list of 326
quality indicators for palliative care found in a recent systematic
review [43]. Four of these 326 indicators were related to the actual
place of death and eight indicators concerned dying at the
preferred place of care. From these twelve indicators, we selected
two indicators that we could calculate with the existing EURO
SENTI-MELC dataset. The first quality indicator selected, ‘the
percentage of patients dying at home’, comes from a set of quality
indicators developed in Italy for palliative home care [40]. The
indicator is calculated using ‘the number of patients dying at
home’ as the numerator and ‘the total number of patients’ as the
denominator. The performance standard specified by the devel-
opers is that at least 95% of the patients receiving home palliative
care should die at home. The second quality indicator selected
concerns ‘the percentage of patients who died in the location of
their preference’. This quality indicator was found in two indicator
sets that were developed for a wider range of settings [24,38]. In
one of the sets [38] the indicator was calculated using ‘the number
of relatives who indicate that the patient died in the location of
his/her preference’ as the numerator and ‘the total number of
relatives for whom this quality indicator was measured’ as the
Quality Indicators Concerning Place of Death
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denominator. We used the GP’s knowledge of the patient’s
preferred place of death to calculate this indicator.
Data Collection
The data needed for the calculation of these two quality
indicators were taken from the data of the EURO SENTI-MELC
study in which GPs recorded the characteristics of recently
deceased patients on weekly basis using a standardised question-
naire. Recall bias was minimised by requiring registration to be no
more than one week after the GP had been informed of the
patient’s death [47]. In the questionnaire, GPs were asked about
the actual place of death [at home or living with family, in a care
home (Belgium and Italy)/elderly home (the Netherlands and
Spain), in hospital, in a palliative care unit/hospice, or elsewhere
(namely); dichotomised into ‘at home’ (i.e. at home or living with
family) vs. ‘not at home’].
In addition, the patient’s preference regarding place of death
was asked in the question ‘Were you informed (verbally or in
writing) of the patient’s preference regarding place of death?’. If
the answer to this question was ‘yes’, the GP was then asked
‘Where did this patient prefer to die?’ and could choose from these
options: at home or living with family, in a care home (Belgium
and Italy)/elderly home (Netherlands and Spain), in hospital, in a
palliative care unit/hospice or elsewhere (namely). The question-
naire also included the following questions:
N The provision of palliative care by the GP, as judged by the
GPs themselves [no; yes, but not until death; yes, until death;
dichotomized into ‘yes’ and ‘no’];
N The importance of care goals in the second to fourth week
before the patient died, as judged by the GPs themselves:
treatment aimed at cure, treatment aimed at prolonging life
and treatment aimed at palliation, rated on a five-point Likert
scale (1 ‘not at all important’ to 5 ‘very important’). These
scores were dichotomized into the categories ‘important to
very important’ (scores of 4 and 5) and ‘not so important’
(scores of less than 4).
Informed Consent and Patient Anonymity
After being informed of the objectives and procedures of the
study, participating GPs gave written informed consent at the
beginning of each registration year. Strict procedures regarding
Figure 1. Flowchart of the sample selection. *We excluded patients if place of residence was known for #15 days in the last month of life OR if
place of residence was known for ,30 days and a transition took place during this period.
doi:10.1371/journal.pone.0093762.g001
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patient anonymity were employed during data collection and
entry; every patient received an anonymous reference code from
their GP and any identifying patient and GP data (such as date of
birth, postcode and GP identification number) were replaced with
aggregate categories or anonymous codes.
Ethical Approval
The protocol of this study was approved by the Ethical Review
Board of Brussels University Hospital of the Vrije Universiteit
Brussel (2004), Belgium, and the Local Ethical Committee,
‘Comitato Etico della Azienda U.S.L. n. 9 di Grosseto’ (2008),
Tuscany, Italy. In the Netherlands and Spain, no ethical approval
is required for the posthumous collection of anonymous patient
data.
Statistical Analysis
We calculated the quality indicator ‘the percentage of patients
dying at home’ from the question concerning the place of death.
The quality indicator ‘the percentage of patients who died in the
place of their preference’ was calculated based on the combined
information concerning actual and preferred place of death.
Descriptive statistics were used to describe the study population
and the quality indicator scores.
To enable a valid comparison between countries in quality
indicator scores, the quality indicator scores were standardised for
patients’ gender, age at death, cause of death and diagnosis of
dementia, using the distribution observed in the study population
as a whole as the reference distribution.
Multivariable logistic regression analyses were performed to
identify the care characteristics associated with dying at home and
dying at the place of preference adjusting for patient character-
istics. The patient characteristics used for adjustment were gender
[‘male’ vs. ‘female’], age at death [‘18–64’, ‘65–84’ or ‘85 and
older’], cause of death [‘cancer’ vs. ‘non-cancer’] and diagnosis of
dementia [‘no’, ‘yes, mild dementia’ and ‘yes, severe dementia’].
The care characteristics analysed were ‘GP provided palliative
care’ [‘yes’ vs. ‘no’] and care goals in the last 2–4 weeks of life of
‘treatment aimed at cure’, ‘treatment aimed at prolonging life’ and
‘treatment aimed at comfort/palliation’ [‘important to very
important’ vs. ‘not so important’]. We performed a separate
analysis per country, using a single multivariable model for each
country, including the confounders (age, gender, cause of death,
diagnosis of dementia) and the predictors (‘GP provided palliative
care’ and the three care goals). We retained the confounders in the
model regardless of their statistical significance. The analyses were
performed using IBM SPSS Statistics software, Version 20.0 (IBM
Corp., 2011, Armonk, NY), with a significance level a,0.05.
Results
Description of the Sample
Of the original 7411 red deaths, GPs considered 4877 deaths as
non-sudden. Exclusion of long-term care facility residents in all
four countries left a total number of 3752 deaths: 1036 for
Belgium, 512 for the Netherlands, 1639 for Italy and 565 for Spain
(see Figure 1). In all countries except for Italy, the majority of the
patients in the samples were male (Table 1). About one quarter of
the Belgian and Dutch samples were aged 85 or older, whereas this
group of the very elderly comprised around 40% in Italy and
Spain. Malignancy was the main cause of death in all countries,
but the proportion in the Netherlands was higher (60.8% versus
40.8–48.4%). Fewer patients were diagnosed with dementia in the
Netherlands than in the other three countries (7.3% versus 17.4–
27.7%).
In all countries except for Belgium, the majority of patients
received palliative care from their GP (Table 1). Palliation was
considered an important care goal in the last 2–4 weeks of life for
the majority of the patients in all countries. Cure was still an
important care goal in 14.2–24.0% of patients and prolonging life
in 21.5–39.3% (Table 1).
Quality Indicator Scores per Country
Belgium had the lowest scores on the standardised quality
indicator ‘the percentage of patients dying at home’: in Belgium,
only 35.3% of the sample of GPs’ patients living at home and with
a non-sudden death died at home. Home deaths accounted for
49.1–50.6% in the samples in the other three countries (Table 2).
Italy had the lowest scores for the standardised quality indicator
‘the percentage of patients who died at their preferred place of
death’: in Italy, 67.8% of the GPs’ patients who lived at home and
died non-suddenly died at the preferred place, while this
percentage was highest in Spain (86.0%) (Table 2). These quality
indicator scores standardised for gender, age, cause of death and
diagnosis of dementia, differed slightly from the crude, observed
percentages, by 0.3% to 7.8% (see Table 2).
Feasibility of Collecting the Necessary Data for the
Quality Indicators
The quality indicator concerning the actual place of death had
very few missing values (Table 2). The number of cases where the
questions were not answered or inconsistently answered was also
low for the quality indicator concerning the preferred place of
death (Table 2). On the other hand, high numbers of unknown
preferences were seen for this indicator: from 39.6% in the
Netherlands to 70.3% in Italy (Table 2). The proportion of cases
where the preferences were unknown differed substantially
between home deaths and deaths outside the home (p,0.001 in
all four countries): the percentage of unknown preferences was
higher for deaths outside the home, and this was the case for all
four countries (Table 3).
Comparison of the Outcomes of the Two Quality
Indicators
A fair, simple comparison of the outcomes of two indicators is
impossible, firstly due to the high percentage of missing
information for the preferred place of death and secondly due to
the fact that the proportion of missing values varies between
countries and place of death (from 17.5% missing for patients in
the Netherlands who died at home to 89.8% missing for patients in
Spain who did not die at home, Table 3). For 71% of the patients
in Belgium and 80% of the patients in the Netherlands who died at
home, this was in accordance with their preferences known by the
GP (Table 3). In Italy and Spain, these percentages were lower
(38% and 47% respectively). Some people did not die at home but
did die in the location of their preference, from 3% (Italy) to 15%
(the Netherlands). The reverse (people who died at home when
that was not the preferred place) occurred too.
Care Characteristics Associated with Quality Indicators
Receiving palliative care from the GP is positively associated
with dying at home (Table 4). This association is greatest in
Belgium and the Netherlands (OR of 8.37 and 13.23 respectively).
If cure is an important care goal in the last 2–4 weeks of life,
people are less likely to die at home. This association is only
significant in Belgium and Spain (OR of 0.57 and 0.48
respectively). If prolonging life is an important care goal in the
last weeks of life, people are less likely to die at home. This
Quality Indicators Concerning Place of Death
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Table 1. Characteristics of the patients and of the care provided per country.
BELGIUM
(N=1036) THE NETHERLANDS (N=512)
ITALY
(N=1639)
SPAIN
(N=565)
N (%) N (%) N (%) N (%)
PATIENT CHARACTERISTICS
Gender* Female 471 (45.6) 235 (46.4) 857 (52.3) 249 (44.6)
Male 563 (54.4) 271 (53.6) 782 (47.7) 309 (55.4)
Age at death{ 18–64 199 (19.4) 113 (22.1) 217 (13.2) 64 (11.3)
65–84 559 (54.4) 280 (54.7) 779 (47.5) 268 (47.4)
85 and older 269 (26.2) 119 (23.2) 643 (39.2) 233 (41.2)
Cause of death` Cancer 501 (48.4) 310 (60.8) 767 (47.9) 226 (40.8)
Cardiovascular diseases (except stroke) 135 (13.0) 62 (12.2) 327 (20.4) 105 (19.0)
Respiratory diseases 95 (9.2) 42 (8.2) 117 (7.3) 59 (10.6)
Neurologic diseases 47 (4.5) 14 (2.7) 89 (5.6) 29 (5.2)
CVA - stroke 57 (5.5) 18 (3.5) 149 (9.3) 47 (8.5)
Other 200 (19.3) 64 (12.5) 151 (9.4) 88 (15.9)
Diagnosed dementia1 No 844 (82.6) 458 (92.7) 1183 (73.1) 401 (72.4)
Yes, mild dementia 102 (10.0) 22 (4.5) 228 (14.1) 79 (14.3)
Yes, severe dementia 76 (7.4) 14 (2.8) 207 (12.8) 74 (13.4)
CARE CHARACTERISTICS
GP provided palliative care|| No 573 (55.4) 264 (39.7) 725 (44.3) 207 (38.8)
Yes 462 (44.6) 299 (60.3) 910 (55.7) 326 (61.2)
Cure is a (very) important care goal in week 2–4 before death" 227 (24.0) 60 (14.2) 230 (16.5) 85 (19.5)
Prolonging life is a (very) important care goal in week 2–4
before death**
304 (31.9) 90 (21.5) 558 (39.3) 112 (26.7)
Palliation is a (very) important care goal in week 2–4
before death{{
647 (68.5) 374 (87.8) 781 (60.2) 304 (67.1)
*Missing values: Belgium N=2, the Netherlands N= 6, Italy no missing values, Spain N= 7.
{Missing values: Belgium N= 9, the Netherlands, Italy and Spain no missing values.
`Missing values: Belgium N= 1, the Netherlands N = 2, Italy N = 39, Spain N= 11.
1Missing values: Belgium N= 14, the Netherlands N = 18, Italy N= 21, Spain N = 11.
||Missing values: Belgium N=1, the Netherlands N= 16, Italy N= 4, Spain N= 32.
"Missing values: Belgium N= 90, the Netherlands N = 88, Italy N = 244, Spain N= 132.
**Missing values: Belgium N= 84, the Netherlands N = 94, Italy N = 219, Spain N= 146.
{{Missing values: Belgium N=91, the Netherlands N= 86, Italy N= 342, Spain N = 112.
doi:10.1371/journal.pone.0093762.t001
Table 2. Observed and standardised quality indicator (QI) scores per country.
BELGIUM
(N=1036)
THE NETHERLANDS
(N=512) ITALY (N=1639)
SPAIN
(N=565)
% of patients dying at home 34.7% 52.5% 50.9% 51.3%
Standardised % of patients dying at home* 35.3% 50.6% 49.1% 50.5%
N unanswered questions{ 7 1 3 11
% of patients who died in the location of their preference` 72.3% 83.2% 69.7% 87.9%
Standardised % of patients who died in the location of their
preference*
72.6% 75.4% 67.8% 86.0%
N unanswered or inconsistently answered questions 7 10 7 66
N (%) preference unknown by GP 592 (57.5%) 199 (39.6%) 1147 (70.3%) 334 (66.9%)
*These percentages have been standardised for gender, age, cause of death and diagnosis of dementia.
{These patients were excluded from our study (see Figure 1).
`This quality indicator was only calculated when preference was known: Belgium (n = 437), the Netherlands (n = 303), Italy (n = 485) and Spain (n = 165).
doi:10.1371/journal.pone.0093762.t002
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association was only significant in Italy and Spain (OR 0.75 and
0.41 respectively). Palliation as an important care goal does not
seem to have a consistent association with the place of death.
Dying at the place of preference is also positively associated with
receiving palliative care from the GP in all countries, except for
Spain (Table 4). The associations of other care characteristics with
dying at the preferred place are not statistically significant.
Discussion
This is the first cross-national study to compare two quality
indicators concerning the actual and preferred place of death for
patients living at home who died non-suddenly. The percentage of
home deaths varied between 35.3% (Belgium) and 50.6% (the
Netherlands). Of patients whose preference for place of death was
known, 67.8% (Italy) to 86.0% (Spain) died in the location of their
preference. The quality indicator concerning the percentage of
home deaths is easy to collect and measurement by GPs is feasible.
However, the feasibility of the indicator concerning dying at the
preferred place of death is hampered due to the high percentage of
patients’ preferences unknown by the GP (39.6%–70.3%). Despite
the high percentage of unknown preferences, the results indicate
that there is a strong overlap between home deaths and deaths in
the preferred location. Quality indicator scores are related to care
characteristics: patients receiving palliative care from the GP were
more likely to die at home and to die at the place of preference;
and people were less likely to die at home if ‘cure’ or ‘prolonging
life’ was an important care goal in the last 2–4 weeks of life.
Regarding the feasibility of collecting these data with the help of
GPs, the quality indicator concerning home deaths had very few
missing values, which shows that calculating this quality indicator
with data gathered by GPs is feasible. The number of unanswered
or inconsistently answered questions was also low for the quality
indicator concerning the preferred place of death. However, high
numbers of unknown preferences (39.7–69.8%) were seen for this
indicator. Other studies have found unknown preference rates
varying between 12% and 64% [1,2,12,30,31,46,51]. The
proportion of unknown preferences was highest in the group of
non-home deaths in all four countries, which is consistent with the
findings of previous GP sentinel network studies [30,52].
Exploring patients’ preferences may be a challenging process,
because both the GP and the patient have to recognise the
approaching end of life and have to be willing to talk about this
subject [20,21]. In addition, some patients might not have a strong
or pronounced preference and recording a definitive answer might
be difficult. Patients also differ in the ability or willingness to
express their preferences: culturally-related inhibitions preventing
patients from talking openly about death or a low level of
educational might hamper timely discussion [2,20,27].
The indicator for the actual place of death has a defined
performance standard of 95%, meaning that at least 95% of the
patients receiving home palliative care should die at home [40].
One could argue that applying this performance standard to our
data set is not realistic, since not all the patients in the data set
received home palliative care, in contrast to the original indicator
set. Alternatively, in the absence of a well-defined performance
standard we can apply the ‘best-practice norm’ principle: take a
look at which country scores best and recommend this score as a
target that other countries should aim for in future. In this study,
one could therefore 51% as the minimum for the proportion of
home deaths as a best-practice norm (the highest score, achieved
in the Netherlands) and a minimum of 86% of patients dying at
the preferred place if the preferred place was known by the GP
(the highest score, achieved in Spain). This could be a way to
overcome the absence of a performance standard, using a relative
rather than an absolute norm as a threshold value for the quality of
care.
We also saw that there is a strong overlap between dying at
home and dying in the preferred location, found in all countries.
Taking into account the unknown preferences, where we do not
know if the preference was met, we can be sure that the majority of
Belgian and Dutch patients (71% and 80% respectively) died at
home according to their wishes, whereas this was only the case in a
minority of Italian and Spanish patients (38% and 47%
respectively). Of the people who did not die at home, 3% to
15% still died in their place of preference. These patients were not
included in the ‘dying at home’ quality indicator, suggesting that
the indicator concerning preference covers a wider group of
patients who died as preferred.
In addition, we revealed that some care characteristics were
associated with the quality indicators, namely whether the GP
provided palliative care and whether ‘cure’ or ‘life prolongation’
was an important treatment goal in the last two to four weeks of
life. These effects are consistent with the existing literature:
receiving chemotherapy in the last month of life has been
associated with a reduced likelihood of a home death [11]; the
provision of palliative care by the GP has been associated with an
increased likelihood of home death [5,19,30,53–57]; dying in the
preferred place of death has been associated with GP involvement
and GP home visits [32,35]. The exact role of the GP in the
provision of health care in general and more specifically in the
provision of palliative care differs between countries. In the
Netherlands, the GP has not only a high level of responsibility as a
gatekeeper of referrals to hospital care and specialist care in
general [47] but also plays the main role in the delivery of
generalist palliative care at home [58,59]. GPs in Spain also fulfil a
gatekeeper function [47], but share the responsibility of the
organisation for palliative care with home care teams [60].
Palliative care is also a shared responsibility of GPs and
multidisciplinary palliative home care teams in Belgium [61] and
Italy [62,63]; in these countries, GPs are not gatekeepers in
general, but they do have a coordinating role in the healthcare
system since most people have a GP who they consult regularly.
Although the role of GPs in the four countries differs, having the
GP provide palliative care was positively associated with dying at
home and dying in the preferred place of death in all four
countries. This suggests that improving these specific aspects, e.g.
in this case improving the provision of palliative care by the GP
and improving the GP-patient communication concerning prefer-
ences at the end of life (including the preferred place of death) can
improve the quality of palliative care, which may then be reflected
in higher quality indicator scores.
Although quality indicators are developed to provide an
overview for a care setting or country as a whole, not for
individual patients, we do think that it is important to keep the
perspective of individual patients in mind when thinking about
realistic performance standards for these indicators. Achieving a
situation in which all patients die at home or all preferences are
known might not be desirable or realistic. Home deaths may be
suggested as an outcome of high-quality palliative care, but might
give the impression that home deaths are the golden standard
while for some patients this is not the best or preferred option. It
misses out small minorities of patients who died in their preferred
location elsewhere or who died at home without preferring home.
Hence, it might seem that the percentage of patients dying at the
preferred place of death is a better indicator, as it takes into
account all preferences met in all locations. However our study
showed that at present it is not feasible for GPs to collect data for
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the indicator on preferred place of death due to the high
percentage of cases where the preferences are unknown to the GP.
We therefore recommend that GPs actively improve their
communication with patients so that they are able to find out
and comply with patients’ preferences. In cases where the GP is
not aware of the patient’s preference, we recommend measuring
the indicator concerning the preferred place of death via relatives,
as was originally intended in the original indicator set and was
found to be feasible in a first test [38]. Another option is that, in
the meantime, place of death could be used as a proxy, since there
is a big overlap between the two indicators.
Furthermore, we should note that for care providers who aim to
monitor and improve the quality of care provided, using only one
quality indicator concerning the place of the death is not sufficient.
Using a wider range of quality indicators, concerning different
physical, psychological and spiritual aspects of palliative care, is
necessary to provide a more complete picture of the quality of care
provided [21,43,64].
Strengths and Limitations
This is the first cross-European study using existing data to
compare the percentage of home deaths and the percentage of
patients who died at their preferred place, and to assess their
function as quality indicators for palliative care.
However, a limitation is that GPs themselves stated whether
they had provided palliative care and we have no detailed
information on what GPs considered as ‘providing palliative care’.
The reported preferences were also based on the GP’s own
observation and the high number of unknown preferences shows
GPs did not know all the details of their patients’ preferences. A
possible bias can be that the sampled patients had more contact
with their GPs and were thus able to state their preference more
clearly to their GPs.
Conclusion
The quality indicator ‘the percentage of home deaths’ is easy for
GPs to provide, but might give a narrow view of the quality of
care, implying that home deaths are the golden standard. Hence it
might seem that the quality indicator ‘dying at the preferred place’
is a better alternative, as it takes into account all preferences met in
all locations. However, it is not feasible at present to have this
indicator measured by GPs due to the high percentage of cases
where the preferences are unknown to the GP. We therefore
suggest using information from relatives as long as information
from GPs on the preferred place of death is lacking. Since dying at
the preferred place of death offers great potential for becoming a
good quality indicator for palliative care, we recommend that GPs
pay ample attention to communication at the end of life, exploring
patients’ preferences, including the place of death.
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